Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (341-350 of 522) with videos related to

Pageof 53
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohortMatthew R Cooperberg, Jeffry P Simko, Janet E Cowan, et al.
Urologic Oncology|July 5, 2023
Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancerAvi Baskin, Janet E Cowan, Avery Braun, et al.
JAMA Oncology|June 16, 2022
Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical TrialNeal D Shore, Joseph Renzulli, Neil E Fleshner, et al.
Cancer|April 25, 2008
Active surveillance for the management of prostate cancer in a contemporary cohortMarc A Dall'Era, Badrinath R Konety, Janet E Cowan, et al.
European Urology Oncology|January 31, 2026
A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate CancerKevin Shee, William A Pace, Jonathan J Song, et al.
Prostate Cancer and Prostatic Diseases|October 4, 2018
Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancerColette A Whitney, Lauren E Howard, Stephen J Freedland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Accuracy of Prostate-Specific Antigen Values in Prostate Cancer RegistriesHarsha R Mittakanti, I-Chun Thomas, Jeremy B Shelton, et al.
The Journal of Urology|October 4, 2016
A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical ProstatectomyHao G Nguyen, Sanoj Punnen, Janet E Cowan, et al.
The Journal of Urology|September 6, 2022
Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional CohortKevin Shee, Samuel L Washington, Janet E Cowan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline EndorsementRonald C Chen, R Bryan Rumble, D Andrew Loblaw, et al.
Pageof 53

Showing results (341-350 of 522) with videos related to

Sort By:
Pageof 53
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohortMatthew R Cooperberg, Jeffry P Simko, Janet E Cowan, et al.
Urologic Oncology|July 5, 2023
Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancerAvi Baskin, Janet E Cowan, Avery Braun, et al.
JAMA Oncology|June 16, 2022
Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical TrialNeal D Shore, Joseph Renzulli, Neil E Fleshner, et al.
Cancer|April 25, 2008
Active surveillance for the management of prostate cancer in a contemporary cohortMarc A Dall'Era, Badrinath R Konety, Janet E Cowan, et al.
European Urology Oncology|January 31, 2026
A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate CancerKevin Shee, William A Pace, Jonathan J Song, et al.
Prostate Cancer and Prostatic Diseases|October 4, 2018
Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancerColette A Whitney, Lauren E Howard, Stephen J Freedland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Accuracy of Prostate-Specific Antigen Values in Prostate Cancer RegistriesHarsha R Mittakanti, I-Chun Thomas, Jeremy B Shelton, et al.
The Journal of Urology|October 4, 2016
A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical ProstatectomyHao G Nguyen, Sanoj Punnen, Janet E Cowan, et al.
The Journal of Urology|September 6, 2022
Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional CohortKevin Shee, Samuel L Washington, Janet E Cowan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline EndorsementRonald C Chen, R Bryan Rumble, D Andrew Loblaw, et al.
Pageof 53